Even as biomedical engineer Anirban Sen Gupta refines artificial platelets to stem traumatic bleeding, he and his colleagues are seeking new uses for their synthetic solution.
Apr 18, 2023
0
0
Gaucher (pronounced "go-shay") disease affects one in 450 Jewish people of Ashkenazi (eastern European) descent (one in 10 is a carrier), yet only 1 in 40,000 people in the general population. Of course mutations can happen ...
Dec 9, 2016
0
2
(HealthDay)—A new microchip-flow chamber system (T-TAS) can be used to discriminate and predict bleeding score (BS) in type 1 von Willebrand disease (VWD), according to a study published online Jan. 27 in the Journal of ...
Feb 5, 2016
0
2
"VONVENDI [von Willebrand factor (Recombinant)]", the new drug from Baxalta Incorporated, a global biopharmaceutical company recently spun off from Baxter International, has just been approved by the United States Food and ...
Dec 21, 2015
0
0
U.S. regulators on Tuesday approved the first genetically engineered treatment for the most common inherited bleeding disorder, von Willebrand disease.
Dec 8, 2015
0
0
The first protein engineered to help control bleeding episodes in patients with severe von Willebrand disease (vW disease) has been shown to be safe and effective, according to results of a Phase III trial. Study data were ...
Aug 3, 2015
0
6
Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that ...
Sep 18, 2014
0
0
In response to blood vessel damage, von Willebrand factor (vWF) binds to the exposed extra cellular matrix, recruits platelets to the site of injury, and activates platelets, which promotes thrombis formation. Patients with ...
Nov 25, 2013
0
0
(Medical Xpress)—Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients' blood to discover the cause of the disease in individual patients.
Apr 5, 2013
0
0
In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders.
Jan 8, 2013
0
0
